Ocumetics Technology Corp.

OTC

CA67577H1047

Office Equipment

Market Closed - Toronto S.E. Other stock markets 09:30:00 2024-07-15 am EDT			5-day change	1st Jan Change
0.29 ^CAD	+1.75%		0.00%	-14.71%

Jun. 21	Ocumetics Technology Corp. announced that it has received CAD 3.76 million in funding	CI
May. 30	Ocumetics Technology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Ocumetics Technology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022

May 20, 2022 at 10:08 am EDT

Ocumetics Technology Corp. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported net loss was CAD 0.518293 million compared to CAD 0.149914 million a year ago.

Latest news about Ocumetics Technology Corp.

Ocumetics Technology Corp. announced that it has received CAD 3.76 million in funding	Jun. 20	CI
Ocumetics Technology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 29	CI
Ocumetics Technology Corp. announced that it expects to receive CAD 3.76 million in funding	May. 14	CI
Ocumetics Technology Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 10	CI
Ocumetics Technology Corp. announced that it has received CAD 0.4166 million in funding	Jan. 16	CI
Ocumetics Technology Corp. Announces Successful Completion of Animal Study in Preparation for Its First-In-Human Study, Anticipated to Commence in First Quarter of 2024 in the Dominican Republic	Dec. 07	CI
Ocumetics Technology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 20	CI
Ocumetics Technology Corp. announced that it expects to receive CAD 1 million in funding	Nov. 14	CI
Ocumetics Continues to Meet Significant Development Milestones Lens Design Optimized for Upcoming First in Human Study	23-09-18	CI
Ocumetics Technology Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-28	CI
Ocumetics Technology Corp. announced that it has received CAD 1 million in funding	23-08-13	CI
Ocumetics Technology Corp. announced that it expects to receive CAD 1 million in funding	23-06-21	CI
Ocumetics Technology Corp. Announces CEO Changes	23-06-12	CI
Ocumetics Technology Corp. Announces Executive Changes	23-06-12	CI
Ocumetics Technology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-26	CI
Ocumetics Technology Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-25	CI
Ocumetics Technology Corp. Announces Resignation of Dr. Mark Lee as the President to Take Effect from June 30, 2023	23-04-25	CI
Ocumetics Technology Corp. Announces Resignation of Dr. Mark Lee as Chief Executive Officer, Effective from June 30, 2023	23-04-25	CI
Ocumetics Technology Corp. Auditor Raises 'Going Concern' Doubt	23-04-24	CI
Ocumetics Technology Corp. Announces Successful Completion of Animal Studies	23-02-12	CI
Ocumetics Technology Corp. announced that it has received CAD 0.672108 million in funding	23-01-31	CI
Ocumetics Technology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-17	CI
Ocumetics Technology Corp. announced that it expects to receive CAD 2.25 million in funding	22-10-18	CI
Ocumetics Technology Corp.' Lens Technology Delivers 14-Diopters of Accommodation in Bench Studies	22-08-29	CI
Ocumetics Technology Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-19	CI

Chart Ocumetics Technology Corp.

Duration

Period

More charts

Company Profile

Ocumetics Technology Corp. is a Canada-based research and product development company. The Company specializes in adaptive lens designs. The Company is focused on developing intraocular lens for people over 45 years of age. It is in the preclinical study stage of a technology for the ophthalmic industry. The Bionic Lens, which is an expandable intraocular lens that fits within the natural lens compartment of the eye to eliminate the need for corrective lenses. It is designed to allow the eyeâs natural muscle activity to shift focus from distance to nearby. The Lens consists of self-adapting suspension systems that modulate curvature change. The Lensâs suspension systems are comprised of cushions that are designed to conform to unique parameters of each recipientâs eye. When ciliary muscles relax, during sleep or when the eye focuses upon distant objects, the optical interface is compressed into its high energy state by expansion of the suspension system.

Sector

Office Equipment

Calendar

2024-08-15 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Scientific & Precision Equipment

	1st Jan change	Capi.
OCUMETICS TECHNOLOGY CORP.	-14.71%	25.42M
SHIMADZU CORPORATION	+7.97%	7.99B
TECAN GROUP AG	-5.77%	4.61B
OLINK HOLDING AB	+3.70%	3.25B
JEOL LTD.	+13.70%	2.26B
NINGBO YONGXIN OPTICS CO.,LTD	-37.59%	950M
PARK SYSTEMS CORP.	+2.25%	890M
FOCUSED PHOTONICS (HANGZHOU), INC.	-29.91%	687M
MLOPTIC CORP.	-58.61%	654M
PHENIX OPTICAL COMPANY LIMITED	-31.47%	609M